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ABSTRACT 
Quartz crystal microbalance with dissipation monitoring and total internal reflection fluorescence 
microscopy have been used to investigate binding of norovirus-like particles (noroVLPs) to a 
supported (phospho)lipid bilayer (SLB) containing a few percent of H or B type 1 
glycosphingolipid receptors. Although neither of these GSLs spontaneously form domains, 
noroVLPs were observed to form micron-sized clusters containing typically up to about 30 VLP 
copies, especially for B type 1 which is a higher-affinity receptor. This novel finding is explained 
by proposing a model implying that VLP–induced membrane deformation promotes VLP 
clustering; a hypothesis that was further supported by observing that functionalized gold 
nanoparticles were able to locally induce SLB deformation. Since similar effects are likely possible 
also at cellular membranes, our findings are interesting beyond a pure biophysicochemical 
perspective, as they shed new light on what may happen during receptor-mediated uptake of 
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MAIN TEXT 
The formation of small protein and lipid clusters or nanoscopic domains in lipid membranes is 
among the central subjects in current bio-membrane physical chemistry.1 Another central subject 
is the interaction of viruses or biologically inspired nanoparticles with lipid membranes.2-3 Herein, 
we show how these subareas can merge. Our focus is on the human norovirus, which belongs to 
the class of non-enveloped RNA viruses. Due to the earlier absence of robust and simple cell 
culture models of this virus, most of the related in vitro studies (see, e.g., Refs. 4-7) have been 
performed by employing norovirus-like particles (noroVLPs) which are recombinant hollow 
capsids with a diameter of ~40 nm, each containing about 180 copies of the major capsid protein 
(VP1). We used such VLPs in combination with a phospholipid bilayer with a few mole percent 
of H type 1 or B type 1 glycosphingolipids (GSLs), which served as receptors with different 
affinity to the VP1. The molecular structure of these lipids is the same except for an additional 
terminal galactose in the oligosaccharide chain of B type 1, a difference sufficient to significantly 
influence the VLP binding affinity as well as kinetics.8-9 Fluorescence labelling of hexahistidine-
tagged noroVLPs made it possible to combine quartz crystal microbalance with dissipation 
(QCM–D) monitoring with total internal reflection fluorescence (TIRF) microscopy to investigate 
VLP binding kinetics and the spatial noroVLP distribution on a laterally mobile supported lipid 
bilayer (SLB).  
In our experiment, the binding affinity of noroVLPs to H type 1 and B type 1 GSLs was 
compared by using QCM-D to measure the corresponding binding kinetics to SLBs with the GSL 
concentration ranging from 0.34 to 6.25 mol% (Fig. 1). The initial linear rate of the resonance 
frequency shift (dDf/dt) in QCM–D measurements upon noroVLP binding (see time traces in Fig. 
S2) displays a non-linear dependence on the GSL concentration in SLB (Fig. 1a) indicating a 
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transition from reaction- to diffusion-limited kinetics with increasing GSL concentration. For B 
type 1, this transition occurs at lower GSL concentration and within a ~3 times narrower 
concentration window compared to H type 1, implying that in the former case the noroVLP 
achieves a firm attachment involving fewer bonds with GSLs. In other words, the binding affinity 
(energy of ligand-receptor pair) of noroVLP towards B type 1 is higher, agreeing with previous 
studies 8-10.  
 
Figure 1. a) Initial rate of binding of noroVLPs obtained from QCM-D measurements, displayed 
as dDf/dt versus GSL concentration in SLB. The corresponding QCM–D time traces are shown in 
Fig. S2. b) A scheme illustrating the post-binding labelling of noroVLPs and TIRF micrographs 
exhibiting signal from the fluorescently labelled noroVLPs bound to SLB with (i) 0.78 and (iii) 
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3.9 mol% H type 1, (ii) 0.35 and (iv) 0.7 mol% B type 1 (the intensity contrast of the images is the 
same except for [iii]). Binding was performed from a 1.1 nM noroVLP suspension with subsequent 
labelling of bound particles using ~40 nM trisNTA–Alexa647 (details in Sec. S3B). c) Integrated 
intensity distribution of neutravidin-coated fluorescent beads adhered to a glass surface (as a 
reference) and noroVLPs on SLBs with 0.78 and 0.7 mol% H type 1 and B type 1, respectively. 
The images were acquired immediately after post-binding labelling and the intensity distributions 
were extracted employing the image analysis as described elsewhere11. 
To analyze the spatial distribution of SLB-bound noroVLPs with TIRFM, we implemented a 
post-binding labelling, i.e., noroVLPs were first bound to the SLB and then labelled with trisNTA–
Alexa 647 (see schematic in Fig. 1b and details in Sec. S3B of SI). Due to a nanomolar binding 
affinity (equilibrium dissociation constant, Kd) of trisNTA towards hexahistidine the conjugation 
of the fluorescent tags to noroVLPs is essentially irreversible over experimental timescales.12 The 
fluorescent signal upon addition of trisNTA–Alexa647 to the SLBs without pre-bound noroVLP 
was weak (Fig. S5), verifying that the TIRFM micrographs in Fig. 1b [i] and [ii] indeed represent 
fluorescence staining of noroVLPs, here obtained for SLBs with 0.78 and 0.35 mol% H type 1 and 
B type 1, respectively. Other than the absolute surface coverage of noroVLP there is hardly any 
detectable difference in the fluorescence distribution at this low GSL content in the SLB. At 
increased norovirus coverages obtained at 3.9 and 0.7 mol% of the H type 1 and B type 1, 
respectively, a difference in the fluorescence distribution is however significant (Fig. 1b [iii] and 
[iv]). In particular, upon binding to the SLB containing H type 1 the particle fluorescence emission 
displays a homogeneous distribution, whereas for B type 1, the fluorescent emission appears to 
originate from discrete objects with a relatively heterogeneous distribution in both their signal 
intensity and spatial extension (0.5 to 2 µm, i.e. beyond the diffraction-limit). Such difference in 
particle distribution between B type 1 and H type 1 bilayers was observed also at higher GSL 
concentrations in the SLB (Fig. S8) and within a wide range of noroVLP coverage (Fig. S9).  
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The integrated fluorescence intensities of discrete particles/objects detected on SLBs with 0.78 
mol% H type 1 and 0.7 mol% B type 1 (Fig. 1b [i] and [iv]) were analysed to compare the 
dependence of the intensity distribution on the receptor type (Fig. 1c). Despite the quite different 
initial binding rates (Fig. 1a), we chose to compare the particle intensity distribution at a similar 
total GSL concentration in SLB because the total GSL content appeared to significantly influence 
the noroVLP coverage. By optimizing the TIRFM measurement conditions we found a comparable 
window of noroVLP coverage (with a strong enough attachment) on SLBs with ~0.7 mol% of the 
GSLs, at which single particles and clusters can be discerned. Both intensity distributions in Fig. 
1c have an overlapping narrow peak at low intensity, which is attributed to separate single 
noroVLPs; an interpretation that is supported by the fact that i) noroVLPs are monodisperse (Fig. 
S1), ii) the labelling distribution is narrow13 (Sec. S3D), and iii) the intensity distribution width is 
comparable to that of discrete neutravidin-coated fluorescent beads adhered to a glass surface. 
Since there were no signs of VLP aggregation in suspension (Sec. S2A), the additional, wider 
distributions of higher intensities seen in Fig. 1c are attributed to aggregation of noroVLPs after 
binding. The difference in the wider distribution of higher intensity is likely due to a significantly 
higher tendency for aggregation of the noroVLPs on the SLB containing the B type 1 compared to 
the H type 1, which was further supported by similar observations at different noroVLP coverages 
(Fig. S10). The width of this wider distribution in case of H and B type 1 varies from 1.5 to 3 and 
1.5 to 4 in a logarithmic scale, respectively. This means that the aggregates/clusters on H and B 
type 1 contain roughly from 1 to 30 (101.5) and 1 to 300 (102.5) noroVLPs, respectively. More 
specifically, the average and FWHM (full width of half maximum) of the cluster intensity 
distributions on H and B type 1 (Fig. 1c and Fig. S10) indicate that the clusters typically contain 
from 1 to ~10 and 3 to ~30 noroVLPs, respectively. 
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To scrutinize the formation kinetics and growth of noroVLP clusters, time-lapse TIRFM movies 
were acquired during the binding of pre-labelled noroVLPs (fluorescently labelled in suspension, 
see Sec. S3C) to a SLB with the higher affinity B type 1 receptor (Movie 1). The respective TIRFM 
micrographs obtained at different time-points display the change of the fluorescent signal upon 
particle binding together with the appearance of an increasing number of discrete clusters (Fig. 
2a). The corresponding ensemble signal intensity has a fast increase (within 12 s) followed by a 
weak increase over a time period of 22 minutes (black scatter points in Fig. 2b). On closer 
inspection, the initial intensity rise has a relatively fast component, which is likely to originate 
from a weak unspecific membrane staining, followed by a slower component attributed to specific 
noroVLP binding (inset in Fig. 2b). Simultaneously, in addition to the fast intensity rise a slow but 
substantial increase in the intensity of the signal from the discrete clusters was observed (Fig. 2b). 
This local signal enhancement proceeded several minutes after noroVLP injection and also after 
the ensemble signal intensity saturated. These observations imply that after the initial noroVLP 
binding to B type 1, either newly arrived particles preferentially bind adjacent to the pre-bound 
particles or the laterally-mobile bound particles prefer to localize at adjacent positions appearing 
as clusters of bound noroVLPs. The latter type of cluster growth was clearly detected at a few 
instances (see top panel in Fig. 2a [ii]), but was difficult to quantify statistically due to weak signal 
per noroVLP and the dye photo-bleaching effect on the signal. Except for few rapidly formed 
clusters (blue scatter points in Fig. 2b) and stepwise growing clusters (green scatter points in Fig. 
2b) most of the clusters show a continuous but saturating growth, as no further increase in signal 
intensity was detected between 40 minutes to 7 hours after noroVLP addition. A plausible 
explanation to this observation would be depletion of noroVLP in suspension or B type 1 in the 
bilayer. However, since further cluster growth was not observed upon replenishing the noroVLP 
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suspension and a similar trend in the cluster growth was observed on SLBs with a higher (3.45 
mol%) B type 1 content (not shown), the observation might, as discussed further below, originate 
from local depletion of GSLs in SLB induced by local structural alterations of the SLB-noroVLP 
complexes. 
 
Figure 2. a) Scheme of the binding of fluorescently labelled noroVLPs to B type 1 embedded in 
the SLB and the corresponding TIRFM micrographs at times as indicated illustrate the change in 
the fluorescence signal (i) at the ensemble system and (ii) from a growing discrete cluster (in a red 
square). Size of each TIRFM image in (i) and (ii) is 10 ´ 10 µm2 and 3 ´ 3 µm2, respectively. b) 
Change in the normalized average intensity of the ensemble (black scatter points, extracted from 
100 ´ 100 µm2 TIRFM movie) and from 4 discrete clusters on a SLB with B type 1 during the 
binding of fluorescent noroVLPs. The binding was done from 0.82 nM fluorescently labelled 
noroVLPs to a SLB with 0.7 mol% B type 1, see Movie 1. The gaps between the scatter points 
(between 1-6 min, 6.7-8.7 min, and 18.7-20.8 min) are parts of the measurement when TIRF 
images were not acquired in order to reduce the photobleaching effect. The data were normalized 
with respect to the corresponding maximum average intensity. 
A plausible explanation to the observed noroVLP cluster formation might be that the relatively 
high GSL concentration in the membrane induces spontaneous formation of GSL domains prior to 
noroVLP binding. Such transient submicron liquid-ordered GSL-containing domains were indeed 
observed14-15, but only in presence of cholesterol or at very high (50 mol%) sphingomyelin or GSL 
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content, i.e., conditions very unlike the ones reported herein. It is in this context relevant to stress 
that non-transient lipid domains tend to fuse together or grow continuously (Ostwald ripening) to 
eventually form lipid domains of several microns in size.16-18 However, neither the cluster growth 
nor the saturation of the growth (Fig. 2b) is consistent with intrinsically formed GSL domains, 
since this was observed only in response to VLP binding. This interpretation is further supported 
by experiments in which the SLB-bound noroVLPs were exposed to a fucose-binding lectin that 
compete with the VLP for binding to the GSLs, a concept that was previously used to scrutinize 
the nature of multivalent virus interactions19 by depleting the available receptors. After lectin-
addition, the noroVLP clusters became weakly mobile (Movie 2) and multiple instances of cluster 
division were detected (Fig. S13), observations that both make the existence of glycolipid domains 
unlikely. 
Excluding the possibility of spontaneous GSL-domain formation, we speculate that the clusters 
observed are inherently related to the SLB–noroVLP interaction. Compared to the protein or lipid 
domain formation or clustering of small toxins the physics behind virus or VLP clustering in a 
lipid membrane is expected to be quite different. In particular, due to their small size (~5 nm) 
proteins are able to directly contact each other near a flat membrane. In contrast, upon binding of 
viruses or VLPs with a spherical geometry to a flat membrane, the contact region is significantly 
smaller than the virus or VLP dimension. From geometric consideration, noroVLP (total 180 
binding sites) can bind 6 to 10 GSLs under the assumption that the membrane remains flat.8 In this 
scenario, even if noroVLPs bind adjacently on the SLB, their contact points will be separated by 
the diameter of the VLP, i.e., 40 nm, making noroVLP-induced local GSL accumulation very 
unlikely on a flat SLB. Furthermore, clustering was observed to be significantly more pronounced 
in the B type 1 case where the ligand-receptor interaction is stronger and thus the formation of a 
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greater number of bonds between of noroVLP and B type 1 is energetically favorable. Thus, 
despite the weak energy of the individual interactions, the multivalent interaction could possibly 
be strong enough to induce local lipid bilayer deformation at the binding sites even in the presence 
of a solid support underneath the lipid bilayer. To scrutinize this effect, one can first refer to 
membrane-mediated lateral interaction between attached proteins or colloidal spheres (see Ref. 20 
and references therein). The corresponding models are, however, not directly applicable to our 
case because the noroVLP-SLB interaction occurs via GSLs (1 nm extension of the hydrophilic 
oligosaccharide unit from the SLB), while in these models proteins/colloids directly interact with 
a membrane. In addition, these models typically do not take the membrane-support interaction into 
account. 
 
Figure 3. Schemes of lipid-membrane deformation during attachment of a single virus or VLP to 
(a) a host-cell membrane and (b) supported membrane, and (c) attachment of two viruses or VLPs 
to a supported membrane. The membrane receptors mediating the attachment are not shown. The 
interaction of virus/VLPs with the membrane occurring via receptors is considered to be 
appreciable so that it results in the local rupture of the membrane-support bonds and membrane 
bending. Note that after the addition of the second particle [(c) vs. (b)] the membrane-particle 
contact area calculated per particle does not change while the area of the bended membrane and 




























be calculated per particle) become smaller. The membrane-particle contacts are energetically 
favourable, their relative role becomes higher if two particles are located nearby, and accordingly 
such particle arrangements are preferable. 
A more relevant class of models for our system are those focusing on virus entry into cells by 
endocytosis,21-22 as schematically illustrated in Fig.3. In such models, the interaction energy of a 
virus with the host cell is typically represented as r b cE E E E= + + , where r b c,  ,  E E E  are the 
energy terms corresponding to the attractive interaction with membrane receptors, membrane 
bending, and deformation of cytoskeleton or, more specifically, of actin filaments, respectively 
(see corresponding expressions in Sec. S4). During the initial phase of virus entry (at engulfment 
depth h < virus radius, see Fig 3a) cE is negligible22 and the process is often energetically favorable 
provided r bE E> . In our case (Fig. 3b), by analogy, the interaction energy can be rewritten as, 
r b sE E E E= + + , where sE  is the energy needed to rupture membrane-support bonds (details in 
Sec. S4). The rupture of the membrane-support bonds is energetically favorable provided that 
r b sE E E> + . If the rupture of the membrane-support bonds takes place, the membrane bending 
near a bound virus/VLP may be appreciable and cause a local membrane deformation. In this case, 
the adjacent location of virus/VLP (Fig. 3c) becomes energetically favorable because it allows the 
particle to gain more contact area, i.e., more VLP-GSL bonds can be formed, as well as reduce 
both the membrane bending energy and the energy needed to rupture the membrane-support bonds. 
As a result, particles will experience a locally attractive membrane-mediated lateral interaction. 
Each energy term in the latter energy expression is considerably greater than kBT and accordingly 
the attractive membrane-mediated particle-particle interaction can be much larger as well. As 
detailed in Supporting Information, the VLP-GSL contact has for B type 1 a relatively high affinity 
(on the scale of 7 kBT) suggesting that membrane deformation would be energetically favorable. 
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As a consequence of such a structural deformation of the SLB, the free diffusion of available GSLs 
may be hindered and result a local depletion of receptors and thereby a saturating growth of the 
clusters. Importantly, these arguments are qualitatively applicable not only to viruses/VLPs 
attachment to a SLB but also to attachment of viruses to the cell membranes and their aggregation 
prior to membrane invagination (the latter was scrutinized in Refs. 20 and 23), because the 
structures of the expressions for the interaction energies are similar.  
To further support the feasibility of such local SLB deformation upon particle attachment, we 
used QCM-D to track irreversible binding of synthetic model noroVLPs or, more specifically, of 
gold-PEG core-shell nanoparticles with a hydrodynamic diameter of ~40 nm displaying 50-60 
biotin ligands at their periphery24 to both a biotinylated SLB (mobile) and thiol-PEG-biotin 
(immobile) functionalized surface via a linker layer of streptavidin (Fig. 4). Even at the same 
streptavidin coverage, the corresponding saturated particle coverage was lower on the SLB than 
on the thiol–PEG functionalized surface. This is attributed to the fact that mobile biotins in the 
SLB “recruit” mobile streptavidin at adjacent positions, thereby increasing the number of bound 
streptavidin per particle while lowering the number of available streptavidin on the surface. On a 
thiol–PEG surface, however, the conjugated streptavidin is immobile, thus the number of available 
streptavidin within the nanoparticle contact area is limited and, accordingly, surface-bound 
streptavidin cannot be depleted due to multivalent nanoparticle–streptavidin interaction. Further, 
upon subsequent injection of streptavidin to the gold particles bound on the thiol–PEG surface, the 
observed response shows that multiple biotin binding sites on bound nanoparticles are not yet 
engaged in bonds and thus still available. In contrast, SLB-bound gold nanoparticles barely showed 
any additional streptavidin binding (Fig. 4b), indicating that a majority of the biotins on the 
nanoparticles were already engaged in binding with streptavidin on the SLB. To explain this, we 
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argue that a rigid thiol-PEG surface is unable to deform, while a SLB is flexible enough to partially 
wrap the bound nanoparticles, as schematically illustrated in Fig. 4a, thereby lowering the number 
of available streptavidin binding sites (i.e., biotins). This interpretation is further supported by light 
scattering and confocal imaging measurements, demonstrating a drastic reduction in mobility for 
gold nanoparticles engaging multiple ligand-receptor pairs and membrane restructuring in the 
contact region, respectively (Sec. S3K, Supporting Information). 
 
Figure 4. a) Scheme of a sandwich binding assay on a mobile SLB and an immobile thiol–PEG 
functionalized surface using biotinylated gold nanoparticles 40 nm in diameter. b) Time-trace of 
resonance frequency change (3rd overtone) in QCM–D upon subsequent binding of streptavidin, 
biotinylated gold nanoparticles, and streptavidin to a biotinylated SLB and a surface functionalized 
with thiol–PEG-biotin. Formation of a SLB on a silica-coated QCM–D sensor is characterized 
with a two-phase change in the frequency upon injection of biotinylated lipid vesicles. The gold 
coated QCM–D sensor was functionalized with thiol–PEG-biotin prior to mounting it in the QCM–
D instrument. To achieve the same streptavidin coverage on both surfaces, the biotin content in 
the SLB and on the thiol–PEG functionalized surface was adjusted accordingly. The inset shows 
the ratio of the final frequency shift upon injection of streptavidin (third step) and the 
corresponding shift for gold nanoparticle binding (second step). Error bars represent the statistical 
deviation.  
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In conclusion, we show in this work that the binding kinetics of noroVLPs differed significantly 
between two GSLs, with higher affinity for B type 1 compared to H type 1 receptors (Fig. 1). 
However, somewhat unexpectedly, despite any indications of GSL aggregation in the SLBs, also 
the tendency to form small-scale noroVLP aggregates was observed, in particular on SLBs 
containing the higher-affinity receptor B type 1. Our results also suggest that SLBs can indeed be 
locally deformed upon attachment of nanoparticles and qualitatively explains the mechanism of 
noroVLP cluster formation on SLBs containing a relatively high affinity GSL receptor in line with 
the model suggested above to explain VLP clustering. In the related context of protein clustering 
on cell membranes, this phenomenon has long been associated with lipid sorting in membranes25, 
trans-signalling between lipid layers26, and their endocytosis20. Thus membrane-deformation 
induced virus clustering on cell membranes might also function as signaling intermediates or low 
energy transition states between bound and internalized state as described by recent theoretical 
studies.23 Another related remark is that the induction of membrane invaginations on giant uni-
lamellar vesicles (GUVs) was previously studied with noroVLPs of the Dijon strain27. Similar 
membrane invaginations were observed also for the polyomavirus SV40, and have been suggested 
to correspond to endocytosis intermediates.28 Even though the noroVLP tubulation study27 was not 
quantitative, a tendency towards more efficient invagination on GUVs with B type 1 than H type 
1 was observed, which is in agreement with our results of preferential noroVLP clustering on SLB 
with B type 1. Further, the interaction between SV40 and its GSL receptor GM1 has been 
thoroughly characterized in terms of affinity, multivalency and diffusion of the virus-receptor 
complex on the cell surface as well as endocytosis.19, 28-30 In terms of the equilibrium dissociation 
constant, Kd, the corresponding affinity of SV4019, 31 appears to be in between that of H type 132 
and B type 1.32 Our already mentioned estimates show that the physically reasonable virus-receptor 
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interaction on the scale of 7 kBT is sufficient for rupture of the membrane-support bonds and VLP 
clustering, suggesting that a similar mechanism to that observed in this work is plausible also in 
the case of SV40. Taken together, earlier observations and our results indicate that the hypothesis 
of virus/VLPs clustering is conceptually important in the context of viral endocytosis, suggesting 
that future experiments should focus on imaging with improved temporal and lateral resolution, 
using GSLs and virus strains with significant different affinities and labeling strategies capable of 
resolving structural change at the molecular scale. Finally, our results are also of interest from the 
perspectives of the use of biologically-inspired nanoscale carriers for intracellular delivery of e.g. 
RNA (this approach is considered to have great potential in therapeutics3), because the interaction 
of such carriers with the host-cell membrane is similar to that of viruses.  
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